Nalaganje...
CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
New advances in the design and manufacture of monoclonal antibodies, bispecific T cell engagers, and antibody-drug conjugates make the antibody-directed agents more powerful with less toxicities. Small molecule inhibitors are routinely used now as oral targeted agents for multiple cancers. The disco...
Shranjeno v:
| izdano v: | J Hematol Oncol |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842223/ https://ncbi.nlm.nih.gov/pubmed/31703740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0819-1 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|